✦ LIBER ✦

Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study

✍ Scribed by Stoter, G.; Fosså, S.D.; Rugarli, C.; Symann, M.; Jasmin, C.; Israel, L.; Bijman, J.Th.; Palmer, P.; Franks, C.R.; Philip, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant interleukin-2 in metastatic

✍ von der Maase, H.; Geertsen, P.; Thatcher, N.; Jasmin, C.; Mercatello, A.; Fosså 📂 Article 📅 1991 🏛 Elsevier Science ⚖ 874 KB

Phase II study of low dose cyclophospham

✍ Walter D. Y. Quan; Grace E. Dean; Gary Lieskovsky; Malcolm S. Mitchell; Raymond 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 384 KB

Phase III, randomised, multicentre trial

✍ Rodolfo Passalacqua; Carlo Buzio; Sebastiano Buti; Camillo Porta; Roberto Labian 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 284 KB

A phase II trial of dose-intensive inter

✍ Leslie Oleksowicz; Janice P. Dutcher 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 123 KB

A phase-II study of low-dose cyclophosph

✍ Albrecht Lindemann; Klaus Höffken; Reinhold E. Schmidt; Volker Diehl; Otto Kloke 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 937 KB

Phase I-II study of everolimus and low-d

✍ Charlotte M Huijts; Saskia J Santegoets; Alfons J van den Eertwegh; Laura S Pijp 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 244 KB